L27 + 28 - The Modern Drug Discovery Pipeline / Design Techniques Flashcards

1
Q

Why do drugs fail getting to market?

A

Wrong molecule made
- efficacy
- safety
- commercial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is disease state assessed by?

A

Taking clinical samples from patients or using established models

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What methods are used to identify the target?

A
  • genomic
  • proteomic
  • genetic association
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What do genomic methods seek to identify?

A

Differential expression of mRNA in the disease state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mRNA used for in target identification?

A
  • make protein
  • changes to levels of mRNA can lead to changes in the amount of protein present in the disease state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do proteomic methods seek to identify?

A
  • differential expression of proteins in the disease state
  • functional chanfes to proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is high throughput screening?

A

Technique where large numebrs of chemical compounds (libraries) are rapidlt tested for activity against our chosen target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the advantage of high throughput screening?

A

Highly automated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are considerations of high throughput screening?

A
  • screening is random
  • active compounds usually provide us with a starting point
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is virtual screening?

A

Computational methods to predict:
- how a compound will bind to a protein
- what compound might bind to a protein
- how strongly a compound might bind to a protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are advantages of virtual screening?

A

Don’t need to physically make the compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are disadvantages of virtual screening?

A

Need to know exact position in 3D space of all atoms in protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does protein crystallography reveal?

A

3D structure of protein and bound compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does visualisation of complex proteins and potential drugs help scientists with?

A

Understand mechanism of action of the drug and to inprove the design of a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does visualition of these complex proteins and potential durgs use?

A

Computational ball and stick model of atoms and bonds, as well as surfaces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the steps in virtual screening?

A
  • put compound in approximate area where binding occurs
  • generic algorithm encodes orientation of compound and rotatable bonds
  • optimise binding to protein
    = provides rational screening method to identify scaffold
17
Q

How do you optimise binding to protein?

A
  • minimise energy
  • hydrogen bonding
  • hydrophobic interactions
18
Q

What is combinatorial chemistry?

A

Techniques for producing large numbers of compounds
- in a short period of time
- using defined reaction routes and a large variety of starting materials and reagents

19
Q

What is an example of combinatorial chemistry?

A

Multi-component reaction
- quickly generates a library of 160,000 compounds with dif R1, R2, R3, and R4

20
Q

What are requirements for combinatorial chemistry?

A
  • highly efficient chemistry
  • limited work-up, isolation and purification
  • rapid throughput
21
Q

What are advantages if combinatorial chemistry is achieved?

A
  • vast increases in productivity
  • chemistry bottlenecks in drug discovery process can be prevented
  • companies can patent sooner
  • cost savings and increased time for revenue generation
22
Q

What does molecular modeling use?

A

Similar methods to virtual screening
- carried out after we already have out lead compound

23
Q

What is molecular modeling used to try to optimise?

A

Pharmacophores for improved binding (efficacy)

24
Q

How do you optimise pharmacophore binding to the protein?

A
  • minimise energy
  • hydrogen bonding
  • hydrophobic interactions
25
Q

What do ADME techniques help model?

A

How the drug will likely act in the. Body

26
Q

What can these methods be (for ADME)?

A

experimental
- using cellular tissue, or in silico, using computational models

27
Q

What are in vitro ADME models based around?

A

Real tissue samples
- have similar properties to those in the body
= cuts down on animal tests (pre-screen)
- enables discovery of data on many more compounds

28
Q

What does the caco-2 permeability assay help to understand?

A

Suitability of a compound for oral dosing
- predicting human intestinal permeability and drug efflux

29
Q

How does the cac0-2 permeability assay investigate the intestinal permeability?

A

By measuring the rate of transport of a compound across the caco-2 cell line

30
Q

What is the caco-2 cell line derived from?

A

Human colon carcinoma
- resemble intestinal epithelial cells (formation of polarised monolayer, well-defined brush border on the apical surface and intercellular junctions)

31
Q

What can computational methods can predict compound properties?

A
  • logP, lipophilicity measure
  • solubility
  • permeability
  • CyP450 metabolism